Qing S Zeng

Title: Qing S Zeng: Innovator in Antibody Production

Introduction

Qing S Zeng is a notable inventor based in Alhambra, CA (US), recognized for his contributions to the field of antibody production. With a focus on improving serum preparations, Zeng has made significant strides in enhancing the efficiency of monoclonal antibody production.

Latest Patents

Zeng holds a patent for "IgG depleted serum preparations and methods for antibody production." This innovative method involves preparing serum that is depleted of IgG, which is crucial for the production of IgG monoclonal antibodies. The process includes contacting animal serum with protein G or protein A before adding it to base media, resulting in a superior cell culture medium that is free from serum-derived IgG antibodies. The patent also details improved media preparations for the culture of antibody-producing cells, incorporating the antibody-depleted serum and enhanced methods for producing the antibodies.

Career Highlights

Zeng is affiliated with the John Wayne Cancer Institute, where he applies his expertise in antibody production to advance cancer research. His work is pivotal in developing more effective treatments through innovative serum preparations.

Collaborations

Zeng collaborates with Reiko F Irie, who is also involved in research related to antibody production. Their partnership exemplifies the collaborative spirit in scientific research, contributing to advancements in the field.

Conclusion

Qing S Zeng's innovative work in antibody production and serum preparations highlights his significant contributions to the scientific community. His patent and ongoing research efforts continue to pave the way for advancements in medical treatments.